Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Guard vs Old Guard: Tofacitinib vs Methotrexate in DMARD-Naive Rheumatoid Arthritis.

Mayo Clinic proceedings·2026
Same author

Impact of the COVID-19 pandemic on autoimmune rheumatic disease diagnoses.

The Lancet. Rheumatology·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.

Journal for immunotherapy of cancer·2026
Same author

Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).

Rheumatology and therapy·2026
Same author

Hospitalization risk in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study.

Seminars in arthritis and rheumatism·2026
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 31, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

Rheumatoid Arthritis.

Jeffrey A Sparks1

  • 1From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. (J.A.S.).

Annals of Internal Medicine
|January 1, 2019
PubMed
Summary
This summary is machine-generated.

Rheumatoid arthritis (RA) is an autoimmune disease causing joint pain and swelling. Early diagnosis and new treatments significantly improve patient outcomes and reduce associated health risks.

More Related Videos

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.9K
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.1K

Related Experiment Videos

Last Updated: Jan 31, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.9K
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

3.1K

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Rheumatoid arthritis (RA) is a prevalent systemic inflammatory autoimmune disease.
  • Characterized by joint pain, swelling, and stiffness, RA impairs physical function and quality of life.
  • RA patients face increased risks of infection, respiratory disease, osteoporosis, cardiovascular disease, cancer, and mortality.

Purpose of the Study:

  • To highlight the importance of familiarity with diagnosing and managing rheumatoid arthritis.
  • To underscore the improved prognosis and management of RA due to recent advancements.

Main Methods:

  • Review of clinical presentation and diagnostic considerations for RA.
  • Discussion of the increased health risks associated with RA.
  • Overview of recent therapeutic advancements in RA management.

Main Results:

  • Early diagnosis and aggressive treatment are crucial for RA management.
  • Expanded therapeutic options, including disease-modifying antirheumatic drugs (DMARDs), have improved outcomes.
  • Significant improvements in RA management and long-term prognosis have been observed.

Conclusions:

  • Familiarity with RA diagnosis and management is essential for clinicians.
  • Advancements in treatment have markedly improved the outlook for RA patients.
  • Aggressive and early intervention is key to better managing rheumatoid arthritis and its complications.